Please activate JavaScript!
Please install Adobe Flash Player, click here for download


ITSySTEmSRAD·BOOK 201264 1 Skaane P, Gullien R, Eben EB, et. al. Reading time of FFDM and tomosynthesis in a population-based screening program. Radiological Society of North America annual meeting. Chicago, Il, 2011. 2 Bernardi D, Ciatto S, Pellegrini M, et. al. Prospective study of breast tomosynthesis as a triage to assessment in screening. Breast Cancer Res Treat. 2012 Jan 22 [Epub ahead of print]. 3 FDA PMA submission P080003. This advertisement is intended for medical professionals and/or specific product users residing in Europe and other countries and should not be considered as a solicitation or promotion of any product or of an indication of any product that is not authorized by the laws and regulations of another country where the reader resides. This advertisement could refer to products that are or may not be available a instead of any particular country, and/or may not have received market clearance by a governmental regulatory body for indications and restrictions in different countries. ADS-00667 To help radiologists find cancers missed with conventional 2D mammography. 1 The Selenia® Dimensions® system allows you to harness the power of breast tomosynthesis to identify and characterize individual breast structures with clarity and certainty never before possible. To learn more about breast tomosynthesis please visit Selenia Dimensions breast tomosynthesis delivers demonstrated benefits including: • Breast cancer screening with breast tomosynthesis has a higher cancer detection rate than conventional 2D mammography.1 • Masses, distortions and asymmetric densities are better visualized with breast tomosynthesis.2 • Breast tomosynthesis gives radiologists the confidence to reduce recall rates.3